174 related articles for article (PubMed ID: 3989631)
1. Plasma enteroglucagon in the control of childhood celiac disease.
Stenhammar L; Strömberg L; Kilander AF; Lindstedt G; Lundberg PA
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):325-30. PubMed ID: 3989631
[TBL] [Abstract][Full Text] [Related]
2. Determination of enteroglucagon in plasma for detection of celiac disease in children.
Kilander AF; Stenhammar L; Lindstedt G; Lundberg PA
Clin Chem; 1984 Jan; 30(1):77-80. PubMed ID: 6690155
[TBL] [Abstract][Full Text] [Related]
3. Plasma enteroglucagon related to malabsorption in coeliac disease.
Kilander AF; Dotevall G; Lindstedt G; Lundberg PA
Gut; 1984 Jun; 25(6):629-35. PubMed ID: 6735247
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease.
Kelly CP; Johnston CF; Nolan N; Keeling PW; Weir DG
Gastroenterology; 1989 May; 96(5 Pt 1):1350-3. PubMed ID: 2703119
[TBL] [Abstract][Full Text] [Related]
5. Circulating oxyntomodulin-like immunoreactivity in healthy children and children with celiac disease.
Le Quellec A; Clapié M; Callamand P; Lehmann M; Kervran A; Bataille D; Rieu D
J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):513-8. PubMed ID: 9822314
[TBL] [Abstract][Full Text] [Related]
6. Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis.
Deprez P; Sempoux C; Van Beers BE; Jouret A; Robert A; Rahier J; Geubel A; Pauwels S; Mainguet P
Regul Pept; 2002 Dec; 110(1):55-63. PubMed ID: 12468110
[TBL] [Abstract][Full Text] [Related]
7. Small-bowel mucosa in asymptomatic children with celiac disease. Mucosal changes with gluten-free diets.
Congdon P; Mason MK; Smith S; Crollick A; Steel A; Littlewood J
Am J Dis Child; 1981 Feb; 135(2):118-21. PubMed ID: 7468543
[TBL] [Abstract][Full Text] [Related]
8. Mucosal recovery in treated childhood celiac disease (gluten-sensitive enteropathy).
McNicholl B; Egan-Mitchell B; Stevens F; Keane R; Baker S; McCarthy CF; Fottrell PF
J Pediatr; 1976 Sep; 89(3):418-24. PubMed ID: 956966
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal peptide profile in children with celiac disease.
Hernanz A; Polanco I; Codoceo R; Lama R; Vazquez C
J Pediatr Gastroenterol Nutr; 1987; 6(3):341-5. PubMed ID: 2892903
[TBL] [Abstract][Full Text] [Related]
10. Adaptive increase in peptide YY and enteroglucagon after proctocolectomy and pelvic ileal reservoir construction.
Armstrong DN; Ballantyne GH; Adrian TE; Bilchik AJ; McMillen MA; Modlin IM
Dis Colon Rectum; 1991 Feb; 34(2):119-25. PubMed ID: 1993408
[TBL] [Abstract][Full Text] [Related]
11. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
[TBL] [Abstract][Full Text] [Related]
12. [Enteroglucagon cells in the jejunal mucosa in celiac disease, before, during and after diet treatment. Immunohistochemical study].
Ceccamea A; Pietroletti R; Carlei F; Dominici C; Lezoche E; Polak JM
Minerva Pediatr; 1985 Oct; 37(19):699-703. PubMed ID: 4088174
[No Abstract] [Full Text] [Related]
13. IgA anti-gliadin antibodies in the monitoring of gluten challenge in celiac disease.
Valletta EA; Trevisiol D; Mastella G
J Pediatr Gastroenterol Nutr; 1990 Feb; 10(2):169-73. PubMed ID: 2303968
[TBL] [Abstract][Full Text] [Related]
14. Intestinal mast cells in different stages of celiac disease.
Suranyi Y; Freier S; Faber J; Dollberg L
Isr J Med Sci; 1986 May; 22(5):370-5. PubMed ID: 3744785
[TBL] [Abstract][Full Text] [Related]
15. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet.
Lee SK; Lo W; Memeo L; Rotterdam H; Green PH
Gastrointest Endosc; 2003 Feb; 57(2):187-91. PubMed ID: 12556782
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge.
Dotsenko V; Oittinen M; Taavela J; Popp A; Peräaho M; Staff S; Sarin J; Leon F; Isola J; Mäki M; Viiri K
Cell Mol Gastroenterol Hepatol; 2021; 11(1):13-32. PubMed ID: 32745639
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation, plasma enteroglucagon and plasma gastrin levels in starved and refed rats.
Goodlad RA; Al-Mukhtar MY; Ghatei MA; Bloom SR; Wright NA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 43(1):55-62. PubMed ID: 6136120
[TBL] [Abstract][Full Text] [Related]
18. Variability of gluten intolerance in treated childhood coeliac disease.
McNicholl B; Egan-Mitchell B; Fottrell PF
Gut; 1979 Feb; 20(2):126-32. PubMed ID: 428824
[TBL] [Abstract][Full Text] [Related]
19. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
20. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
Holst JJ; Sørensen TI; Andersen AN; Stadil F; Andersen B; Lauritsen KB; Klein HC
Scand J Gastroenterol; 1979; 14(2):205-7. PubMed ID: 432544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
